TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 116 | 126 | 188 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 33 | 21 | 79 |
EBITDA | 32 | 21 | 79 |
Total assets | 197 | 233 | 234 |
Current assets | 197 | 233 | 234 |
Current liabilities | 1 | 19 | 3 |
Equity capital | 190 | 208 | 224 |
- share capital | 4 | 5 | 5 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 96.4% | 89.3% | 95.7% |
Turnover per employee | 116 | 126 | 188 |
Profit as a percentage of turnover | 28.4% | 16.7% | 42.0% |
Return on assets (ROA) | 16.8% | 9.0% | 33.8% |
Current ratio | 19700% | 1226.3% | 7800% |
Return on equity (ROE) | 17.4% | 10.1% | 35.3% |
Change turnover | 0 | -58 | -17 |
Change turnover % | 0% | -31% | -8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.